Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 25Neoplasm Metastasis 6Metastatic Hormone-sensitive Prostate Cancer 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Stage I Prostate Adenocarcinoma 1Salivary Gland Neoplasms 1Recurrence 1Non-metastatic, Hormone naïve Prostate Cancer 1Neoplasms 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer 1Lymphatic Metastasis 1Insulin Resistance 1Adenocarcinoma of the Prostate 1

Interventions

Metformin 18Inositol 5Exercise 4Pioglitazone 3Insulin 3Ethinyl Estradiol 3drospirenone and ethinyl estradiol combination 2Surveys and Questionnaires 2Cyproterone Acetate 2Acupuncture Therapy 2ziprasidone 1salicylsalicylic acid 1maltodextrin 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1Zoledronic Acid 1Waist-Hip Ratio 1Waist Circumference 1Vitamin D 1Time 1Thioctic Acid 1Tablets 1Sulfasalazine 1Sugars 1Sodium-Glucose Transporter 2 Inhibitors 1Sodium Salicylate 1Saline Solution 1Resistance Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Insulin Resistance × Androgen Antagonists × Clear all
NCT00455624 2013-07-11

Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer

Massachusetts General Hospital

Completed
60 enrolled
Genitourinary

Insulin Resistance, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡